On November 8, a delegation comprising Professor Gao Xia, Director of the Nephrology Department at Guangzhou Women and Children's Medical Center, Professor Li Yingjie, and Professor Deng Huiying visited Shenzhen Cell Valley for exchange and discussion. Our Chairman, Professor Shi Yuanyuan, Chief Scientist Professor Wang Jianxun, Head of Marketing Sun Rui, and Deputy Head of Marketing Yang Jianglong extended a warm welcome to the delegation.

Led by Deputy Head of Marketing Yang Jianglong, Professor Gao and her team toured the smart exhibition hall, the digital monitoring system, and the production workshops, gaining an understanding of Shenzhen Cell Valley's development history, core team, core technology patents, the role and advantages of retroviral vectors in cell therapy, and the Shenzhen and Zhongshan bases for production, R&D, quality management, and industrial talent training. The delegation expressed high appreciation for Shenzhen Cell Valley's advanced technologies, innovative capabilities, and quality control systems.

First, Professor Shi Yuanyuan and Professor Wang Jianxun extended a warm welcome to the nephrology experts from Guangzhou Women and Children's Medical Center. Subsequently, the two sides engaged in discussions on recent corporate R&D progress, cell therapy technologies, viral vector applications, and project implementation plans such as the joint establishment of a cell preparation quality control center. Professor Shi Yuanyuan and Professor Wang Jianxun provided a detailed introduction to Shenzhen Cell Valley's core advantages and its use of domestically leading GMP-grade industrial-scale production processes for retroviral vectors, offering highquality and safe customized target-specific CAR cell preparation services to numerous top-tier tertiary hospitals, and jointly advancing clinical research and application development in cell therapy.

Professor Gao Xia noted that the Nephrology Department of the Women and Children's Medical Center was established in 1980. Under the guidance and development of multiple experts and scholars over the years, it has been dedicated to research and clinical diagnosis and treatment of pediatric kidney diseases. As the strongest pediatric nephrology specialty in South China, the department was honored as the "Strongest Kidney Specialty in Guangdong Province" in 2022, and was approved as the Guangdong Provincial Pediatric Restricted Technology Training Base for Continuous Blood Purification in Children in 2023. The management of severe kidney diseases is a key feature of the specialty.

Through this visit and exchange, both parties expressed their commitment to jointly advancing the scientific research and clinical application of cell therapy in pediatric kidney diseases and related areas.